Prostate Clinical Trials Search

Current State: NCT ID:
Return to Map
TitleStateStatusNCT ID
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesAlaskaRecruitingNCT00079001
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerAlaskaRecruitingNCT00309985
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerAlaskaRecruitingNCT00430183
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate CancerAlaskaRecruitingNCT00567580
Study of Immunotherapy to Treat Advanced Prostate CancerAlaskaRecruitingNCT00861614
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesAlaskaRecruitingNCT00874211
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerAlaskaRecruitingNCT00936390
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerAlaskaRecruitingNCT00942331
Phase 3 Study of Immunotherapy to Treat Advanced Prostate CancerAlaskaRecruitingNCT01057810
Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerAlaskaRecruitingNCT01193257
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerAlaskaRecruitingNCT01234311
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceAlaskaRecruitingNCT01238172
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerAlaskaRecruitingNCT01288911
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineArkansasRecruitingNCT01302067
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerArkansasRecruitingNCT01308580
Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate CancerArkansasRecruitingNCT01514669
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder TumorsArkansasNot yet recruitingNCT01567462
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100ArkansasRecruitingNCT01605227
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyArkansasAvailableNCT01606982